SI-BONE, Inc. Common Stock SIBN
Analyst Ratings
- Consensus
- Buy — 6 Buy · 0 Hold · 0 Sell (6 analysts)
- Avg. Price Target
- $25.00 (-0.4% downside)
Key Stats
- Today's Range
- $24.85 – $25.70
- 50-Day Range
- $17.82 – $25.92
- 52-Week Range
- $11.48 – $25.92
- Volume
- 745K shs
- Average Volume
- 828K shs
- Market Cap
- $1.15 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.41%
- Days to Cover
- 1.00
About SI-BONE, Inc. Common Stock
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Related Stocks
Compare head-to-head: SIBN vs SYK·SIBN vs BSX·SIBN vs MDLN·SIBN vs RMD
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
